Is your organization missing from this list? Reach out to Leyla Cakici, Strategic Alliance Partnership Coordinator, to learn more about the complimentary strategic partnership program: lcakici@mjhlifesciences.com
Subcutaneous nivolumab under review in EU for solid tumors
FDA approves durvalumab/chemo for muscle–invasive bladder cancer
FDA approves expanded label for 177Lu-PSMA-617 in mCRPC
FDA grants marketing authorization to at-home diagnostic test for STIs